نتایج جستجو برای: idiopathic pulmonary arterial hypertension ipah

تعداد نتایج: 480229  

2017
Grzegorz Kopec Marcin Waligóra Anna Tyrka Monika Komar Natasza Herman Piotr Podolec

Acute vasoreactivity testing is indicated in patients with idiopathic pulmonary arterial hypertension (IPAH) to identify subjects who will respond favorably to long-term treatment with calcium channel blockers (CCB) [1]. The result of the test determines the choice of treatment and predicts survival of the patient [2, 3]. It has been suggested that molecular etiology of IPAH is different in pat...

Journal: :American journal of physiology. Cell physiology 2007
Shen Zhang Hui Dong Lewis J Rubin Jason X-J Yuan

A rise in cytosolic Ca(2+) concentration ([Ca(2+)](cyt)) in pulmonary artery smooth muscle cells (PASMC) is a trigger for pulmonary vasoconstriction and a stimulus for PASMC proliferation and migration. Multiple mechanisms are involved in regulating [Ca(2+)](cyt) in human PASMC. The resting [Ca(2+)](cyt) and Ca(2+) entry are both increased in PASMC from patients with idiopathic pulmonary arteri...

Journal: :Chest 2015
Lars Harbaum Tim Oqueka Antonia Glatzel Jan K Hennigs Nicole Lüneburg Hans Klose

To the Editor: We read with great interest the article in CHEST (June 2015) by Hautefort et al, 1 who demonstrated activity of the T helper 17 pathway in patients with idiopathic pulmonary arterial hypertension (IPAH). Th e authors further substantiated a potential role of an autoimmune pathogenesis in IPAH, a disease defi ned by the absence of known causes or associated conditions. “A fl avor ...

Journal: :Circulation journal : official journal of the Japanese Circulation Society 2008
Satoshi Akagi Hiromi Matsubara Katsumasa Miyaji Etsuko Ikeda Kazuhiro Dan Naoto Tokunaga Kenichi Hisamatsu Mitsuru Munemasa Yoshihisa Fujimoto Tohru Ohe

BACKGROUND Combination therapy has been proposed in treatment algorithms for idiopathic pulmonary arterial hypertension (IPAH), so the additional effects of bosentan in IPAH patients already treated with high-dose epoprostenol (EPO) was evaluated in the present study. METHODS AND RESULTS Bosentan (62.5 mg twice daily) was administered to 8 IPAH patients already being treated with high-dose EP...

Journal: :American journal of respiratory and critical care medicine 2007
Olivier Sanchez Elisabeth Marcos Frédéric Perros Elie Fadel Ly Tu Marc Humbert Philippe Dartevelle Gérald Simonneau Serge Adnot Saadia Eddahibi

RATIONALE Inflammatory cytokines may affect pulmonary vascular remodeling in idiopathic pulmonary arterial hypertension (IPAH). CC chemokine ligand 2 (CCL2) is synthesized by vascular cells and can stimulate monocyte/macrophage migration and smooth muscle cell (SMC) proliferation. OBJECTIVES To investigate the role of CCL2 in IPAH. METHODS CCL2 levels in plasma, monocytes, lungs, and medium...

Journal: :Journal of the American College of Cardiology 2012
Christian Apitz Rainer Zimmermann Joachim Kreuder Christian Jux Heiner Latus Joern Pons-Kühnemann Ines Kock Peter Bride Karsten Grosse Kreymborg Ina Michel-Behnke Dietmar Schranz

OBJECTIVES The purpose of our study was to assess pulmonary endothelial function by vasodilator response to acetylcholine (Ach) administered in segmental pulmonary arteries in children with idiopathic pulmonary arterial hypertension (IPAH). We hypothesized that there was a relationship among pulmonary endothelial response to Ach, severity of the disease, and clinical outcome. BACKGROUND IPAH ...

Journal: :American journal of physiology. Cell physiology 2007
Carmelle V Remillard Donna D Tigno Oleksandr Platoshyn Elyssa D Burg Elena E Brevnova Diane Conger Ann Nicholson Brinda K Rana Richard N Channick Lewis J Rubin Daniel T O'connor Jason X-J Yuan

The pore-forming alpha-subunit, Kv1.5, forms functional voltage-gated K(+) (Kv) channels in human pulmonary artery smooth muscle cells (PASMC) and plays an important role in regulating membrane potential, vascular tone, and PASMC proliferation and apoptosis. Inhibited Kv channel expression and function have been implicated in PASMC from patients with idiopathic pulmonary arterial hypertension (...

Journal: :Disease Models & Mechanisms 2010

Journal: :Archives of cardiovascular diseases 2010
Alain Fraisse Xavier Jais Jean-Marc Schleich Sylvie di Filippo Pascale Maragnès Maurice Beghetti Virginie Gressin Michel Voisin Claire Dauphin Pierre Clerson François Godart Damien Bonnet

BACKGROUND Limited data are available describing paediatric pulmonary arterial hypertension. AIMS To characterize the epidemiology, management and impact on quality of life and outcome of paediatric pulmonary arterial hypertension, excluding persistent pulmonary hypertension of the newborn and pulmonary arterial hypertension caused by congenital heart disease. METHODS In this multicentre st...

Journal: :American journal of respiratory and critical care medicine 2006
Laurence Dewachter Serge Adnot Elie Fadel Marc Humbert Bernard Maitre Anne-Marie Barlier-Mur Gerald Simonneau Michel Hamon Robert Naeije Saadia Eddahibi

RATIONALE Angiopoietins are involved in blood vessel maturation and remodeling. OBJECTIVES One consequence of endothelium-specific tyrosine kinase-2 (Tie2) receptor activation by angiopoietin-1 (Ang1) is the release of endothelium-derived growth factors that recruit vascular wall cells. We investigated this process in idiopathic pulmonary arterial hypertension (iPAH). METHODS Ang1, Ang2, an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید